Chemocentryx Stock Filter Stocks by Fundamentals
CCXIDelisted Stock | USD 51.99 0.00 0.00% |
ChemoCentryx fundamentals help investors to digest information that contributes to ChemoCentryx's financial success or failures. It also enables traders to predict the movement of ChemoCentryx Stock. The fundamental analysis module provides a way to measure ChemoCentryx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChemoCentryx stock.
ChemoCentryx |
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
ChemoCentryx Fundamentals
Return On Equity | -46.96 | |||
Return On Asset | -18.55 | |||
Operating Margin | (353.17) % | |||
Current Valuation | 3.45 B | |||
Shares Outstanding | 70.03 M | |||
Shares Owned By Insiders | 12.01 % | |||
Shares Owned By Institutions | 84.39 % | |||
Number Of Shares Shorted | 7.61 M | |||
Price To Earning | 40.53 X | |||
Price To Book | 10.04 X | |||
Price To Sales | 97.66 X | |||
Revenue | 37.28 M | |||
Gross Profit | (51.07 M) | |||
EBITDA | (127.6 M) | |||
Net Income | (133.09 M) | |||
Cash And Equivalents | 328.62 M | |||
Cash Per Share | 4.61 X | |||
Total Debt | 73.2 M | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 4.54 X | |||
Book Value Per Share | 5.18 X | |||
Cash Flow From Operations | (53.5 M) | |||
Short Ratio | 4.89 X | |||
Earnings Per Share | (0.94) X | |||
Number Of Employees | 178 | |||
Beta | 1.23 | |||
Market Capitalization | 3.64 B | |||
Total Asset | 78.16 M | |||
Retained Earnings | (441.3 M) | |||
Working Capital | 66.54 M | |||
Current Asset | 72.03 M | |||
Current Liabilities | 5.49 M | |||
Z Score | 19.1 |
About ChemoCentryx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChemoCentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChemoCentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChemoCentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc. ChemoCentryx operates under Biotechnology classification in the United States and is traded on NMS Exchange. It employs 178 people.
Pair Trading with ChemoCentryx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoCentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoCentryx will appreciate offsetting losses from the drop in the long position's value.Moving together with ChemoCentryx Stock
0.81 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
Moving against ChemoCentryx Stock
0.66 | GFGY | Granite Falls Energy | PairCorr |
0.58 | WXIBF | WuXi Biologics | PairCorr |
0.56 | PRSEF | Prosafe | PairCorr |
0.47 | FINN | First National | PairCorr |
0.44 | AMKBF | AP Mller - | PairCorr |
The ability to find closely correlated positions to ChemoCentryx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoCentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoCentryx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoCentryx to buy it.
The correlation of ChemoCentryx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoCentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoCentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoCentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in ChemoCentryx Stock
If you are still planning to invest in ChemoCentryx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChemoCentryx's history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |